# ImmunoMRI for Assessment of Tumor-associated Macrophages

> **NCT07066436** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Medical University of Vienna** · enrollment: 60 (estimated)

## Conditions studied

- DLBCL - Diffuse Large B Cell Lymphoma

## Interventions

- **DRUG:** MRI contrast-enhancing agents

## Key facts

- **NCT ID:** NCT07066436
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2028-03
- **Final completion:** 2028-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07066436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07066436, "ImmunoMRI for Assessment of Tumor-associated Macrophages". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07066436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*